Loading…
Lobbying Spend
—
Filings
5
Firms Hired
1
Active Period
2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1316
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.413
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.637
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · third_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2017 · third_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1316
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · third_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.413
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
2017 · third_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.637
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · second_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2017 · second_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1316
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · second_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.413
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
2017 · second_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Client expense: — · Firm income: $50,000
Matched citations: S.637
Improving Transparency and Accuracy in Medicare Part D Spending Act
2017 · first_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2017 · first_quarter · Firm: THE MCMANUS GROUP
Education and advocacy regarding drug distribution. H.R. 1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1316
Source: Senate LDA